Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
17,687,735
-
Share change
-
-209,971
-
Total reported value
-
$24,762,165
-
Price per share
-
$1.40
-
Number of holders
-
30
-
Value change
-
-$777,233
-
Number of buys
-
7
-
Number of sells
-
11
Institutional Holders of IMPEL PHARMACEUTICALS INC - COM (IMPLQ) as of Q1 2023
As of 31 Mar 2023,
IMPEL PHARMACEUTICALS INC - COM (IMPLQ) was held by
30 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
17,687,735 shares.
The largest 10 holders included
Kohlberg Kravis Roberts & Co. L.P., NVP Associates, LLC, 5AM Venture Management, LLC, Vivo Capital, LLC, venBio Partners LLC, VANGUARD GROUP INC, LASRY MARC, DCF Advisers, LLC, GEODE CAPITAL MANAGEMENT, LLC, and Laurion Capital Management LP.
This page lists
30
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.